Cunningham L A
Vine Street Clinical Research Center Springfield, Illinois 62701, USA.
Compr Ther. 1997 Jun;23(6):400-6.
Depression and anxiety disorders are common in primary care. Diagnosis is accomplished by applying of specific, data-driven diagnostic criteria published in the DSM-IV. The differential diagnosis is sometimes difficult, but as a general rule the treatment of choice for both conditions is antidepressant medicine. It is very important to remember that anxiety disorders respond very nicely to most antidepressants, but depression does not respond to tranquilizers. BZs, should be reserved for adjunctive use in the early stages of treatment for both anxiety disorders and depression. The azapirone, buspirone, may be used as first line treatment for generalized anxiety disorder and may also augment antidepressants when the patient presents with mixed anxiety and depression. The important point is that when in doubt about either the diagnosis or which drug to choose first it is generally safe to select one of the newer antidepressants discussed in this article.
抑郁症和焦虑症在初级保健中很常见。诊断通过应用《精神疾病诊断与统计手册》第四版(DSM-IV)中公布的特定、数据驱动的诊断标准来完成。鉴别诊断有时很困难,但一般来说,这两种疾病的首选治疗方法都是抗抑郁药。非常重要的是要记住,焦虑症对大多数抗抑郁药反应良好,但抑郁症对镇静剂无反应。苯二氮䓬类药物(BZs)应保留用于焦虑症和抑郁症治疗早期的辅助用药。阿扎哌隆类药物丁螺环酮可作为广泛性焦虑症的一线治疗药物,当患者同时出现混合性焦虑和抑郁时,也可增强抗抑郁药的疗效。重要的一点是,当对诊断或首先选择哪种药物存在疑问时,选择本文讨论的新型抗抑郁药之一通常是安全的。